Intramuscular injections of slow-release lanreotide (BIM 23014) in acromegalic patients previously treated with continuous subcutaneous infusion of octreotide (SMS 201 - 995). - Caron,P.; Cogne,M.; Gusthiot-Joudet,B.; Wakim,S.; Catus,F.; Bayard,F. (Eur J Endocrinol, 1995)